SCHEMBL27597046

SCHEMBL27597046

Cc1nc(N)sc1-c1cccc(S(C)(=O)=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.47
JAK2 O60674 1/20 0.44
CCNT1 O60563 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CDK7 P50613 1/20 0.44
CDK9 P50750 1/20 0.44
CCNH P51946 1/20 0.44
LIMK1 P53667 1/20 0.44
NR1H2 P55055 4/20 0.43
NR1H3 Q13133 1/20 0.43
PIK3CA P42336 3/20 0.42
PIK3CD O00329 2/20 0.42
PIK3CB P42338 2/20 0.42
PIK3CG P48736 2/20 0.42
PI4KA P42356 1/20 0.42
PI4KB Q9UBF8 1/20 0.42
MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL49028 0.99 LOXL2 (0.46) LOXL2JAK2CCNT1CDK1CCNB1
SCHEMBL5063159 0.84 CCNT1 (0.43) LOXL2CCNT1CDK1CCNB1CCNA2
SCHEMBL48725 0.82 PIK3CD (0.58) PIK3CAPIK3CDPIK3CBPIK3CGMEN1
SCHEMBL8083511 0.79 MEN1 (0.54) MEN1KMT2AGAA
SCHEMBL48419 0.77 PIK3CG (0.73) PIK3CAPIK3CDPIK3CBPIK3CGPI4KA
SCHEMBL8084192 0.76 MAPT (0.51) MEN1KMT2A
SCHEMBL9953765 0.76 TGFBR1 (0.48) MEN1KMT2A
SCHEMBL28357067 0.76 MAPT (0.51) MEN1KMT2AGAA
SCHEMBL15651211 0.75 BRD4 (0.47) MEN1KMT2AGAA
SCHEMBL1788763 0.75 PIK3CD (0.51) JAK2CCNT1CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100548996-C 5-phenylthiazole derivatives and their use for the preparation of medicaments NOVARTIS AG (CH) 2009-10-14 CN disclosed
CN-1639139-A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors NOVARTIS AG (CH) 2005-07-13 CN disclosed